Lassa Fever Latest Advances

Find the Latest Research About Lassa Fever

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1237 publications

Guinea Pig Model for Lassa Virus Infection of Reproductive Tract and Considerations for Sexual and Vertical Transmission.

Guinea Pig Model for Lassa Virus Infection of Reproductive Tract and Considerations for Sexual and Vertical Transmission.

Journal: Emerging infectious diseases
Published: January 06, 2026

A One Health trial design to accelerate Lassa fever vaccines.

A One Health trial design to accelerate Lassa fever vaccines.

Journal: Nature medicine
Published: January 02, 2026

Systematic review protocol: evaluation of candidate platforms and vaccines for emerging and re-emerging viral threats.

Systematic review protocol: evaluation of candidate platforms and vaccines for emerging and re-emerging viral threats.

Journal: Systematic reviews
Published: November 26, 2025

O'nyong'nyong Virus Infections in Nigeria: A Case Series.

O'nyong'nyong Virus Infections in Nigeria: A Case Series.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 20, 2025

Viral hemorrhagic fevers - therapeutic trial advances and challenges.

Viral hemorrhagic fevers - therapeutic trial advances and challenges.

Journal: Expert review of anti-infective therapy
Published: November 17, 2025

Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.

Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.

Journal: The New England journal of medicine
Published: November 05, 2025

Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine.

Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine.

Journal: The Journal of general virology
Published: October 06, 2025

Serological evidence of concurrent Lassa virus and SARS-CoV-2 exposure in Ghana- a cross-sectional study.

Serological evidence of concurrent Lassa virus and SARS-CoV-2 exposure in Ghana- a cross-sectional study.

Journal: BMC infectious diseases
Published: September 15, 2025

Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates.

Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates.

Journal: PloS one
Published: September 09, 2025

Robust polyfunctional CD8+ and CD4+ T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein.

Robust polyfunctional CD8+ and CD4+ T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein.

Journal: The Journal of general virology
Published: September 01, 2025

CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques.

CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques.

Journal: JCI insight
Published: August 15, 2025

Lassa fever symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in Liberia.

Lassa fever symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in Liberia.

Journal: The Lancet. Infectious diseases
Published: August 04, 2025
Showing 1-12 of 1,237

Last Updated: 02/24/2026